Beta-lactamase variants

a betalactamase and variant technology, applied in the field of isolated polypeptides with betalactamase activity, can solve the problems of partial or complete loss of enzymatic activity, and achieve the effects of increasing activity, increasing enzymatic activity, and increasing activity

Active Publication Date: 2019-02-14
DA VOLTERRA +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a new enzyme called VIM-2-P that has increased activity and resistance to proteases compared to the wild-type enzyme. It also has better stability, can inactivate a wider range of beta-lactam compounds and has improved production yield. These improvements make it a more effective tool for developing new antibiotics.

Problems solved by technology

This was surprising as deletions or alterations in the structure of the enzyme very often lead to a full or partial loss of enzymatic activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Beta-lactamase variants

Examples

Experimental program
Comparison scheme
Effect test

example 1

tion of the Positions of Interest in the Sequence of VIM-2 Enzyme

[0078]In order to identify amino acid positions relevant for either the enzyme activity, its substrate profile, its stability or its level of production in the host cell, random mutagenesis was used to create a library of blaVIM-2 genes carrying up to 12 mutations. To this end, blaVIM-2 mutants were introduced using an error-prone polymerase chain reaction, in the presence of nucleotide analogues. The blaVIM-2-derived nucleotide sequences were then cloned in a suitable Escherichia coli plasmid vector and the properties of the enzyme carrying various substitutions (thus a laboratory variants deriving from the introduction of mutations in the blaVIM-2 nucleotide sequence) were analyzed using the evaluation of the beta-lactam susceptibility profiles of the strains producing the variants, the determination of the specific-hydrolyzing activity for the degradation of various beta-lactams and the stability of the variant enzy...

example 2

n and Purification of One VIM-2 Variant at One Position

[0080]The VIM-2 variant was produced in Escherichia coli using either a Plac-promoter-based system (using pLB-II high copy number plasmid, as described in Borgianni et al., Antimicrob. Agents Chemother.; 2010; 54:3197-3204) or a T7 promoter-based expression system (using the pET-9a expression plasmid). Briefly, the mutant blaVIM-2 gene was cloned in the plasmid vector pLB-II or pET-9a using the NdeI and BamHI restriction sites, and the resulting plasmid introduced in E. coli DH5α or BL21(DE3) cells by electroporation. The resulting host cell was grown in either Luria-Bertani medium or the rich auto-inducing cell culture medium ZYP-5052 (Studier, F. W. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.) for 24 h, and the culture supernatant clarified by centrifugation. The resulting sample was then concentrated by ultrafiltration and loaded on an anion exchange chromatogr...

example 3

tion of the Increased Resistance to Protease for Variants of VIM-2 Enzyme

[0082]To measure the sensitivity of purified enzyme preparations (e. g. VIM-2, VIM-2 DCT236 and variants thereof, prepared as described in Example 2) to proteolytic degradation by commercially-available purified proteases, the enzyme (final concentration, 50 μg / mL) was incubated, at 35° C., for up to 150 min in a buffer (50 mM HEPES, 50 μM ZnSO4, pH 7.5) containing up to 2.5 mg / mL of trypsin (from bovine pancreas, Type III, Sigma-Aldrich Cat. No. T-8253). The residual activity of the resulting sample was determined by means of a spectrophotometric assay, in which the hydrolysis rate of a 150 μM imipenem solution (in 50 mM HEPES, 50 μM ZnSO4, pH 7.5) was measured and compared to that of the sample at the beginning of the incubation (time, 0 min) or in the absence of protease.

[0083]In these conditions and in the absence of trypsin in the buffer, both tested enzymes (VIM-2 and VIM-2 DCT236) incubated for up to 150...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperaturesaaaaaaaaaa
temperaturesaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability.

Description

FIELD OF THE INVENTION[0001]The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a subclass B1 metallo-beta-lactamase belonging to the VIM-type subgroup variant with improved properties such as improved protease stability.BACKGROUND OF THE INVENTION[0002]Many antibacterial products, in particular antibiotics, may be used in the treatment of bacterial infections. However, antibiotics do not only attack pathogens at the infection site, but also affect the normal bacterial flora which can be found in healthy subjects, and in particular in the gut. The alteration by antibiotics of the colonic commensal flora (also called intestinal microbiota), which is composed of more than ten trillion bacteria from over 500 species, may lead to adverse side effects such as selection of resistant bacteria and potential colonization by resistant bacteria, disruption of no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C12N9/86A61K9/00A61K38/50A61K31/496A61K31/546A61K31/407
CPCC12N9/86C12Y305/02006A61K9/0053A61K38/50A61K31/496A61K31/546A61K31/407
InventorDE GUNZBURG, JEANDOCQUIER, JEAN-DENIS
OwnerDA VOLTERRA